These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 33663315

  • 1. Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps.
    Fan W, Zhang L, Wang X, Jia H, Zhang L.
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):707-718. PubMed ID: 33663315
    [Abstract] [Full Text] [Related]

  • 2. Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors.
    Chen Y, Zhang L, Zhang L, Jiang Q, Zhang L.
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):425-436. PubMed ID: 33445997
    [Abstract] [Full Text] [Related]

  • 3. Discovery of novel tetrahydrobenzo[b]thiophene-3-carbonitriles as histone deacetylase inhibitors.
    Gediya P, Vyas VK, Carafa V, Sitwala N, Della Torre L, Poziello A, Kurohara T, Suzuki T, Sanna V, Raguraman V, Suthindhiran K, Ghosh D, Bhatia D, Altucci L, Ghate MD.
    Bioorg Chem; 2021 May; 110():104801. PubMed ID: 33756235
    [Abstract] [Full Text] [Related]

  • 4. Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells.
    Ling Y, Guo J, Yang Q, Zhu P, Miao J, Gao W, Peng Y, Yang J, Xu K, Xiong B, Liu G, Tao J, Luo L, Zhu Q, Zhang Y.
    Eur J Med Chem; 2018 Jan 20; 144():398-409. PubMed ID: 29288941
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery of 1,3-Disubstituted 2,5-Diketopiperazine Derivatives as Potent Class I HDACs Inhibitors.
    Gong G, Qi J, Lv Y, Dong S, Cao C, Li D, Zhao R, Li Z, Chen X.
    Chem Pharm Bull (Tokyo); 2020 Jan 20; 68(5):466-472. PubMed ID: 32378544
    [Abstract] [Full Text] [Related]

  • 7. Discovery of novel class of histone deacetylase inhibitors as potential anticancer agents.
    El-Awady R, Saleh E, Hamoudi R, Ramadan WS, Mazitschek R, Nael MA, Elokely KM, Abou-Gharbia M, Childers WE, Srinivasulu V, Aloum L, Menon V, Al-Tel TH.
    Bioorg Med Chem; 2021 Jul 15; 42():116251. PubMed ID: 34116381
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Synthesis, biological evaluation, and molecular docking analysis of novel linker-less benzamide based potent and selective HDAC3 inhibitors.
    Routholla G, Pulya S, Patel T, Abdul Amin S, Adhikari N, Biswas S, Jha T, Ghosh B.
    Bioorg Chem; 2021 Sep 15; 114():105050. PubMed ID: 34120025
    [Abstract] [Full Text] [Related]

  • 10. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
    Cai J, Wei H, Hong KH, Wu X, Cao M, Zong X, Li L, Sun C, Chen J, Ji M.
    Eur J Med Chem; 2015 Sep 15; 96():1-13. PubMed ID: 25874326
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
    Guan P, Sun F, Hou X, Wang F, Yi F, Xu W, Fang H.
    Bioorg Med Chem; 2012 Jun 15; 20(12):3865-72. PubMed ID: 22579621
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological evaluation of novel indazole-based derivatives as potent HDAC inhibitors via fragment-based virtual screening.
    Liu J, Zhou J, He F, Gao L, Wen Y, Gao L, Wang P, Kang D, Hu L.
    Eur J Med Chem; 2020 Apr 15; 192():112189. PubMed ID: 32151834
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors.
    Chen J, Li D, Li W, Yin J, Zhang Y, Yuan Z, Gao C, Liu F, Jiang Y.
    Bioorg Med Chem; 2018 Aug 07; 26(14):3958-3966. PubMed ID: 29954683
    [Abstract] [Full Text] [Related]

  • 14. Quinazoline-based hydroxamic acid derivatives as dual histone methylation and deacetylation inhibitors for potential anticancer agents.
    Zheng H, Dai Q, Yuan Z, Fan T, Zhang C, Liu Z, Chu B, Sun Q, Chen Y, Jiang Y.
    Bioorg Med Chem; 2022 Jan 01; 53():116524. PubMed ID: 34847495
    [Abstract] [Full Text] [Related]

  • 15. Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities.
    Chao SW, Chen LC, Yu CC, Liu CY, Lin TE, Guh JH, Wang CY, Chen CY, Hsu KC, Huang WJ.
    Eur J Med Chem; 2018 Jan 01; 143():792-805. PubMed ID: 29223096
    [Abstract] [Full Text] [Related]

  • 16. Discovery of potent HDAC inhibitors based on chlamydocin with inhibitory effects on cell migration.
    Wang S, Li X, Wei Y, Xiu Z, Nishino N.
    ChemMedChem; 2014 Mar 01; 9(3):627-37. PubMed ID: 24285590
    [Abstract] [Full Text] [Related]

  • 17. Novel Pyridine-Based Hydroxamates and 2'-Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity.
    Zwergel C, Di Bello E, Fioravanti R, Conte M, Nebbioso A, Mazzone R, Brosch G, Mercurio C, Varasi M, Altucci L, Valente S, Mai A.
    ChemMedChem; 2021 Mar 18; 16(6):989-999. PubMed ID: 33220015
    [Abstract] [Full Text] [Related]

  • 18. Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors.
    Chen X, Gong G, Chen X, Song R, Duan M, Qiao R, Jiao Y, Qi J, Chen Y, Zhu Y.
    Chem Pharm Bull (Tokyo); 2019 Mar 18; 67(10):1116-1122. PubMed ID: 31582631
    [Abstract] [Full Text] [Related]

  • 19. Design, Synthesis and Biological Evaluation of Novel N-hydroxyheptanamides Incorporating 6-hydroxy-2-methylquinazolin-4(3H)-ones as Histone Deacetylase Inhibitors and Cytotoxic Agents.
    Minh NV, Thanh NT, Lien HT, Anh DTP, Cuong HD, Nam NH, Hai PT, Minh-Ngoc L, Le-Thi-Thu H, Chinh LV, Vu TK.
    Anticancer Agents Med Chem; 2019 Mar 18; 19(12):1543-1557. PubMed ID: 31267876
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of coumarin-based N-hydroxycinnamamide derivatives as novel histone deacetylase inhibitors with anticancer activities.
    Ding J, Liu J, Zhang Z, Guo J, Cheng M, Wan Y, Wang R, Fang Y, Guan Z, Jin Y, Xie SS.
    Bioorg Chem; 2020 Aug 18; 101():104023. PubMed ID: 32650178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.